Requirement for CD154 in the progression of atherosclerosis
Summary
This summary is machine-generated.Genetic disruption of CD154 in mice reduced advanced atherosclerosis plaque area and promoted plaque stability. This highlights the CD40-CD154 pathway
Area Of Science
- Cardiovascular Biology
- Immunology
- Atherosclerosis Research
Background
- Atherosclerosis involves inflammatory pathways, with CD40-CD154 interactions increasingly implicated.
- CD40 is expressed on cells within atherosclerotic plaques, and its activation promotes lesion progression and instability.
Purpose Of The Study
- To investigate the effect of genetic CD154 deficiency on both initial and advanced atherosclerotic lesions in ApoE-/- mice.
- To elucidate the role of CD40-CD154 signaling in the pathogenesis of atherosclerosis.
Main Methods
- Genetic disruption of the CD154 gene in apolipoprotein E-deficient (ApoE-/-) mice.
- Analysis of atherosclerotic lesion development, plaque area, composition, and cellular infiltrate in initial and advanced lesions.
Main Results
- Genetic CD154 deficiency did not affect initial lesion development but significantly reduced plaque area in advanced lesions.
- Advanced plaques in CD154-/-ApoE-/- mice exhibited a more stable phenotype: less lipid content, higher collagen, and reduced T-lymphocyte/macrophage infiltration.
- Plaque area was reduced by 550% in CD154-/-ApoE-/- mice.
Conclusions
- CD40-CD154 signaling is crucial for late-stage atherosclerotic changes, including lipid accumulation and plaque destabilization.
- Targeting the CD40-CD154 pathway may offer therapeutic strategies for stabilizing atherosclerotic plaques.
View abstract on PubMed